A recent investigation suggested an important role of NNMT in EGFR TKI resistance of EGFR-mutated NSCLC cells, and the addition of NNMT inhibitor could overcome this resistance [13]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.